These findings suggest that HP promotes the proliferation of lymphoma B cells by triggering CagA tyrosine-phosphorylation-dependent signals and limits the proliferation of lymphoma cells by activating NFATc1 and its regulation of p21/p27, thus causing G1 phase arrest in these lymphoma B cells. Here, S100A8 is linked to lymphoma.